Literature DB >> 9323065

Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia.

S Tonstad1, H Refsum, P M Ueland.   

Abstract

BACKGROUND: Recently, we reported a relation between plasma total homocysteine (tHcy) in children and cardiovascular disease (CVD) in their male relatives, suggesting that tHcy may partly explain the increased risk related to a family history of CVD. Because individuals with familial hyperlipidemias have an exceptionally high risk of premature CVD, we explored the relationship between tHcy and parental history of CVD in children with familial hypercholesterolemia (FH). METHODS AND
RESULTS: Study subjects were 91 boys and 64 girls (age range, 7 to 17 years) with FH who were treated with a standard lipid-lowering diet at a tertiary care lipid clinic. We conducted a cross-sectional analysis of demographics, the diet, tHcy level, presence of the C677T mutation in the methylenetetrahydrofolate reductase gene (a common genetic cause of elevated tHcy) in children, and the prevalence of parental CVD. tHcy increased after puberty and was inversely related to parental educational level. Intakes of folate, vitamin C, and fruits and vegetables were inversely associated with tHcy, as were serum folate and vitamin B12 (Spearman's rho, -0.2 to 0.4; P<.05). tHcy was increased in children whose parent with FH had experienced CVD compared with children without parental CVD (median [interquartile range], 6.6 [5.3, 8.0] micromol/L versus 5.6 [4.7, 6.8] micromol/L; P=.01). This difference remained significant in multivariate regression analysis. Homozygosity for the C677T mutation was associated with a higher tHcy level and tended to be more frequent in the group with than in the group without a parental history of CVD (18% versus 8%; P=.07).
CONCLUSIONS: These findings suggest that a moderately elevated tHcy level may partly account for the contribution of the family history to risk of CVD in FH. Dietary recommendations for FH should include nutrients that affect homocysteine metabolism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323065     DOI: 10.1161/01.cir.96.6.1803

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

Review 1.  Role of lipid-lowering pharmacotherapy in children.

Authors:  S Tonstad
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Determinants and distributions of plasma total homocysteine concentrations among school children in Taiwan.

Authors:  J B Chang; N F Chu; M H Shen; D M Wu; Y H Liang; S M Shieh
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

3.  Serum homocysteine is related to food intake in adolescents: the Child and Adolescent Trial for Cardiovascular Health.

Authors:  Pamela L Lutsey; Lyn M Steffen; Henry A Feldman; Deanna H Hoelscher; Larry S Webber; Russell V Luepker; Leslie A Lytle; Michelle Zive; Stavroula K Osganian
Journal:  Am J Clin Nutr       Date:  2006-06       Impact factor: 7.045

Review 4.  Atherosclerosis risk factors: the possible role of homocysteine.

Authors:  P C Choy; D Mymin; Q Zhu; K Dakshinamurti; K O
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

5.  The association of plasma homocysteine levels with serum leptin and apolipoprotein B levels in childhood obesity.

Authors:  Figen Narin; Mehmet Emre Atabek; Musa Karakukcu; Nazmi Narin; Selim Kurtoglu; Hakan Gumus; Bekir Coksevim; Rusen Erez
Journal:  Ann Saudi Med       Date:  2005 May-Jun       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.